奥泰生物 (688606.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(奥泰生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度每股收益(元) --1.00-3.001.005.0019.00
 单季度销售毛利率(%) 51.0037.0053.0027.0047.0059.0068.00
 单季度销售净利率(%) 18.0020.0017.00-46.0020.0041.0050.00
 单季度净资产收益率ROE(%) 1.001.001.00-4.001.006.0028.00
 单季度总资产净利率ROA(%) 1.001.001.00-4.001.005.0023.00
单季度财务摘要:
 单季度营业总收入(元) 172,091,296.00151,711,958.00236,135,335.00378,501,815.00286,536,646.00624,612,613.002,098,917,066.00
 单季度营业总成本(元) 131,943,849.00126,981,655.00178,928,269.00346,603,984.00248,511,909.00366,983,695.00788,203,105.00
 单季度营业收入(元) 172,091,296.00151,711,958.00236,135,335.00378,501,815.00286,536,646.00624,612,613.002,098,917,066.00
 单季度营业利润(元) 38,025,983.0044,821,152.0046,254,816.00-204,628,951.0061,683,580.00294,510,804.001,242,262,962.00
 单季度利润总额(元) 37,700,790.0031,206,905.0046,055,549.00-208,211,479.0061,925,023.00290,786,154.001,236,948,636.00
 单季度净利润(元) 30,419,466.0030,490,725.0040,336,129.00-175,712,360.0057,924,162.00253,682,678.001,049,121,215.00
 单季度归属母公司股东的净利润(元) 30,383,844.0030,649,350.0040,532,501.00-176,076,394.0057,837,519.00253,506,402.001,049,210,119.00
 单季度经营活动产生的现金流量(元) 35,553,775.0058,092,075.00-177,675,721.00354,702,107.0031,393,552.0042,715,208.00931,874,152.00
 单季度投资活动产生的现金流量(元) -352,753,744.00326,390,021.0079,996,945.00-289,315,704.00-241,986,349.00-676,340,770.00-56,355,296.00
 单季度筹资活动产生的现金流量(元) -20,884,614.00-529,335,741.00-8,295,694.00-372,773.00-127,536,698.00-241,229,889.007,230,132.00
 单季度现金及现金等价物净增加(元) -343,451,918.00-120,856,554.00-112,314,334.0075,425,156.00-314,768,113.00-834,718,544.00876,698,927.00

前瞻产业研究院